Matthew B. Boxer
Fondatore presso Veralox Therapeutics, Inc.
Profilo
Matthew B.
Boxer has founded Veralox Therapeutics, Inc. in 2017, where he holds the title of Chief Operating Officer & Director.
He was also a Vice President & Head-Translational Medicine at Rebus Holdings, Inc. in 2017.
Dr. Boxer holds a doctorate from The University of Chicago and an undergraduate degree from the University of Vermont.
Posizioni attive di Matthew B. Boxer
Società | Posizione | Inizio |
---|---|---|
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Fondatore | 01/01/2017 |
Precedenti posizioni note di Matthew B. Boxer
Società | Posizione | Fine |
---|---|---|
REBUS HOLDINGS, INC. | Corporate Officer/Principal | 01/12/2017 |
Formazione di Matthew B. Boxer
The University of Chicago | Doctorate Degree |
University of Vermont | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
REBUS HOLDINGS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Health Technology |
- Borsa valori
- Insiders
- Matthew B. Boxer